2nd Quarter - Report
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$185,959
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
BARDA (Biodefense Advanced Research and Development Authority) Funding in FY2009 Supplemental Appropriations Act (PL 111-32) as well as in American Recovery and Reinvestment Act of 2009 (PL 111-5) to fund vaccines and therapeutics against CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threats to the U.S. Funding for BARDA/HHS in the Presidents FY2010 Budget.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EDWARD COOKE | Sr. Director, Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.